eXoZymes employs a proprietary cell-free biomanufacturing platform that achieves over 99% reaction yield at pilot scale, enabling faster production cycles and high purity output. This process operates outside living cells, providing cost efficiency, scalability, and enhanced control. The technology has been transferred to NCTX, a subsidiary responsible for commercialization. NCTX is preparing to launch NCT as a branded nutraceutical ingredient through contract manufacturers (CMOs). Scale-up efforts include downstream optimization, CMO screening, and supply chain readiness. The company holds a portfolio of patents and licenses, including a license from the Regents of the University of California, covering various aspects of its biomanufacturing technology.
Exozymes Inc's Comment on Supply Chain
eXoZymes employs a proprietary cell-free biomanufacturing platform that achieves over 99% reaction yield at pilot scale, enabling faster production cycles and high purity output. This process operates outside living cells, providing cost efficiency, scalability, and enhanced control. The technology has been transferred to NCTX, a subsidiary responsible for commercialization. NCTX is preparing to launch NCT as a branded nutraceutical ingredient through contract manufacturers (CMOs). Scale-up efforts include downstream optimization, CMO screening, and supply chain readiness. The company holds a portfolio of patents and licenses, including a license from the Regents of the University of California, covering various aspects of its biomanufacturing technology.
Sources:
Exozymes Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Exozymes Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
